Klára Borbála Körmendy, Kinga Shenker-Horváth, Alexander Shulze Wenning, Péter Fehérvári, Andrea Harnos, Péter Hegyi, Zsolt Molnár, Kata Illés, Tamás Horváth
PURPOSE: To investigate the rate of residual disease in the Potsic staging system for congenital cholesteatomas. METHODS: A protocol registration was published on PROSPERO (CRD42022383932), describing residual disease as a primary outcome and hearing improvement as secondary. A systematic search was performed in four databases (PubMed, Embase, Cochrane Library, Web of Science) on December 14, 2022. Articles were included if cholesteatomas were staged according to the Potsic system and follow-up duration was documented...
February 13, 2024: European Archives of Oto-rhino-laryngology